Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-02

Clinical Trial Update: Evaluation of the Efficacy of 0.08% Tacrolimus Nanoencapsulated Aqueous Solution Spray Vs. 0.1% Free Tacrolimus Commercial Ointment in the Treatment of Oral Lichen Planus [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating the efficacy of a 0.08% tacrolimus nanoencapsulated aqueous spray compared with 0.1% free tacrolimus ointment for oral …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Free Tacrolimus Topical Ointment (0.1%) (Tacrolimus)
  • Tacrolimus Nanoencapsulated Aqueous Solution Spray (0.08%) (Tacrolimus)

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Oral Erosive Lichen Planus | Phase 1, Phase 2 | Status: RECRUITING